Delivery of clot-busting drug via surgery has benefits, study finds

02/8/2013 | HealthDay News

Researchers tracked 96 patients with intracerebral hemorrhage and found that those who underwent surgery to receive the clot-busting drug tissue plasminogen activator, or tPA, directly in their brains recovered faster than those who were treated with standard therapy. Patients who received tPA were discharged an average of 38 days earlier, and their blood clots dissolved faster. The study appears in the journal Stroke.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY